Join
Live feed
·
PRReleasevia Quantisnow
Cumberland Pharmaceuticals Inc. logo

Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program

ByQuantisnow·Wall Street's wire, on your screen.
CPIX· Cumberland Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CPIX (Cumberland Pharmaceuticals Inc.) and more on Quantisnow.